Pharm
Unfractionated Heparin
search
Unfractionated Heparin
, Heparin
See Also
Low Molecular Weight Heparin
Heparin Induced Thrombocytopenia
Anticoagulation
Indications
Venous Thromboembolism
(DVT, PE) prevention and treatment
Acute Coronary Syndrome
Acute Limb Ischemia
Mechanism
See
Intrinsic Clotting Pathway
Heparin binds to, and potentiates
Antithrombin III
(AT III)
Antithrombin III
binds to an inhibits
Factor X
a
Results in decreased
Thrombin
(and ultimately
Fibrin
) formation
Dosing
Prophylactic for
DVT Prevention
Heparin 5000 Units SQ every 8-12 hours
Dosing
Adult High Intensity Dosing by Weight based Calculations (PE/DVT)
Measure
Total body weight (TBW) in kilograms
Height in inches
Calculate
Lean Body Weight
(LBW) in kilograms
Male: 50 + 2.3 x (height in inches - 60)
Female: 45 + 2.3 x (height in inches -60)
Calculate Dosing Weight
Non-Obese
Dosing Weight (kg): TBW above
Obese (TBW > 1.4 x LBW)
Dosing Weight (kg): (0.4 x TBW) + LBW
Calculate Heparin starting doses
Monitor with aPTT
Bolus: 80 Units/kg
Maximum: 10,000 units
Round to nearest 100 units
Maintenance: 18 Units/kg/hour
Round to nearest 50 units per hour
Alternative Protocol in an unmonitored setting (off label)
Load 333 units/kg SC
Maintenance 250 units/kg SC every 12 hours
Maximum weight 100 kg
Pregnancy
Continue above protocol for at least 5 days of full
Anticoagulation
Next, administer 10,000 units SC every 8 to 12 hours adjusting based on aPTT target 1.5 to 2.5x normal control
Transition back to Heparin infusion, at least 24 hours before delivery
Protocol
Adult High Intensity Therapeutic Dosing Nomogram Using PTT (PE/DVT)
Alternatively, use Anti-Xa Level for monitoring
Protocol follows high intensity starting dose as above
aPTT <35 seconds (<1.2x normal control)
Give 80 units/kg IV bolus
Increase infusion rate by 4 units/kg/hour
Recheck aPTT in 6 hours
aPTT 35 to 45 seconds (1.2 to 1.5x normal control)
Give 40 units/kg IV bolus
Increase infusion rate by 2 units/kg/hour
Recheck aPTT in 6 hours
aPTT 46 to 70 seconds (1.5 to 2.3x normal control)
No change in dosing
Recheck aPTT on the next morning
aPTT 71 to 90 seconds (2.3 to 3.0x normal control)
Decrease maintenance rate by 2 units/kg/hour
Recheck aPTT in 6 hours
aPTT >90 seconds
Stop Heparin infusion for 60 minutes
Decrease maintenance rate by 3 units/kg/hour
Recheck aPTT in 6 hours
Dosing
Child High Intensity Dosing by Weight based Calculations (PE/DVT)
Monitor and adjust infusion based on aPTT or anti-Xa Levels
Starting Protocol 1 (FDA approved package insert)
Bolus 50 units/kg IV
Maintenance: 25 Units/kg/hour
Starting Protocol 2 (off label)
Bolus 75 units/kg IV over 10 minutes
Maintenance: 20 Units/kg/hour
Start 28 units/kg/hour if age <1 year old
Dosing
Adult Low Intensity Dosing by Weight-Based Calculations (
Acute Coronary Syndrome
)
Monitor and adjust infusion based on aPTT (1.5 to 2x normal) or anti-Xa Levels
Load 60 units/kg IV (up to 4000 units IV)
Infuse 12 units/kg/hour
Labs
Therapeutic Dosing Initial (before Heparin)
Partial Thromboplastin Time
(aPTT)
Anti-Xa Level (if used instead of aPTT)
ProTime
(INR)
Complete Blood Count
(CBC) with
Platelet Count
Labs
Therapeutic Dosing Recurring Labs
Partial Thromboplastin Time
(aPTT)
6 hours after bolus and then per nomogram
Anti-Xa Level
May be used as an alternative to aPTT monitoring
Platelet
s
Every 3 days
Minimum: 150,000
Adverse Effects
Bleeding complications
Heparin Induced Thrombocytopenia
Drug Interactions
Medications that increase bleeding risk
Aspirin
Platelet ADP Receptor Antagonist
(e.g.
Clopidogrel
)
NSAID
s (e.g.
Ibuprofen
,
Indomethacin
)
Other
Anticoagulant
s (e.g.
DOAC
s,
Warfarin
)
Glycoprotein IIB/IIIA Inhibitor
Miscellaneous
Antibiotic
s (e.g. some
Penicillin
s,
Cephalosporin
s)
Valproic Acid
AntiThyroid Medications (
Methimazole
,
Propylthiouracil
)
Antimalarials (
Chloroquine
,
Hydroxychloroquine
)
Medications that decrease Heparin efficacy
Digoxin
Tetracycline
Antihistamine
s
Management
Reversal
Protamine
sulfate
Resources
Heparin Injection Solution (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=85b4a714-70cd-42ec-97ce-fd8515b2392e
References
Hamilton (2020) Tarascon Pocket Pharmacopoeia
Olson (2020) Clinical
Pharmacology
, Medmaster Miami, p. 83
Warnock (2022) Heparin, StatPearls, Treasure Island, FL
https://www.ncbi.nlm.nih.gov/books/NBK538247/
Type your search phrase here